Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Ryan

Showing results (591-600 of 649) with videos related to

Pageof 65
Sort By:
Journal of the American Medical Informatics Association : JAMIA|July 13, 2026
PDA (Privacy-Preserving Distributed Algorithms) in action: ten principles for high-quality multi-site clinical evidence generationYong Chen, Jiayi Tong, Yiwen Lu, et al.
International Journal of Radiation Oncology, Biology, Physics|July 1, 2019
Preclinical Combination Studies of an FGFR2 Targeted Thorium-227 Conjugate and the ATR Inhibitor BAY 1895344Katrine Wickstroem, Urs B Hagemann, Alexander Kristian, et al.
Frontiers in Pharmacology|December 13, 2021
Bias, Precision and Timeliness of Historical (Background) Rate Comparison Methods for Vaccine Safety Monitoring: An Empirical Multi-Database AnalysisXintong Li, Lana Yh Lai, Anna Ostropolets, et al.
Drug Safety|July 3, 2014
Bridging islands of information to establish an integrated knowledge base of drugs and health outcomes of interestRichard D Boyce, Patrick B Ryan, G Niklas Norén, et al.
Cell Death & Disease|May 1, 2024
Actin-nucleation promoting factor N-WASP influences alpha-synuclein condensates and pathologyJoshua Jackson, Christian Hoffmann, Enzo Scifo, et al.
Cancer Discovery|April 8, 2024
The Pan-RAF-MEK Nondegrading Molecular Glue NST-628 Is a Potent and Brain-Penetrant Inhibitor of the RAS-MAPK Pathway with Activity across Diverse RAS- and RAF-Driven CancersMeagan B Ryan, Bradley Quade, Natasha Schenk, et al.
American Journal of Otolaryngology|March 5, 2021
Aerosol and droplet generation from orbital repair: Surgical risk in the pandemic eraMichael J Ye, Raghav B Vadhul, Dhruv Sharma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 9, 2019
Mesothelin-Targeted Thorium-227 Conjugate (MSLN-TTC): Preclinical Evaluation of a New Targeted Alpha Therapy for Mesothelin-Positive CancersUrs B Hagemann, Christine Ellingsen, Joachim Schuhmacher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 14, 2019
Preclinical Efficacy of a PSMA-Targeted Thorium-227 Conjugate (PSMA-TTC), a Targeted Alpha Therapy for Prostate CancerStefanie Hammer, Urs B Hagemann, Sabine Zitzmann-Kolbe, et al.
JAMA|October 27, 2020
Association of Ticagrelor vs Clopidogrel With Net Adverse Clinical Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary InterventionSeng Chan You, Yeunsook Rho, Behnood Bikdeli, et al.
Pageof 65

Showing results (591-600 of 649) with videos related to

Sort By:
Pageof 65
Journal of the American Medical Informatics Association : JAMIA|July 13, 2026
PDA (Privacy-Preserving Distributed Algorithms) in action: ten principles for high-quality multi-site clinical evidence generationYong Chen, Jiayi Tong, Yiwen Lu, et al.
International Journal of Radiation Oncology, Biology, Physics|July 1, 2019
Preclinical Combination Studies of an FGFR2 Targeted Thorium-227 Conjugate and the ATR Inhibitor BAY 1895344Katrine Wickstroem, Urs B Hagemann, Alexander Kristian, et al.
Frontiers in Pharmacology|December 13, 2021
Bias, Precision and Timeliness of Historical (Background) Rate Comparison Methods for Vaccine Safety Monitoring: An Empirical Multi-Database AnalysisXintong Li, Lana Yh Lai, Anna Ostropolets, et al.
Drug Safety|July 3, 2014
Bridging islands of information to establish an integrated knowledge base of drugs and health outcomes of interestRichard D Boyce, Patrick B Ryan, G Niklas Norén, et al.
Cell Death & Disease|May 1, 2024
Actin-nucleation promoting factor N-WASP influences alpha-synuclein condensates and pathologyJoshua Jackson, Christian Hoffmann, Enzo Scifo, et al.
Cancer Discovery|April 8, 2024
The Pan-RAF-MEK Nondegrading Molecular Glue NST-628 Is a Potent and Brain-Penetrant Inhibitor of the RAS-MAPK Pathway with Activity across Diverse RAS- and RAF-Driven CancersMeagan B Ryan, Bradley Quade, Natasha Schenk, et al.
American Journal of Otolaryngology|March 5, 2021
Aerosol and droplet generation from orbital repair: Surgical risk in the pandemic eraMichael J Ye, Raghav B Vadhul, Dhruv Sharma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 9, 2019
Mesothelin-Targeted Thorium-227 Conjugate (MSLN-TTC): Preclinical Evaluation of a New Targeted Alpha Therapy for Mesothelin-Positive CancersUrs B Hagemann, Christine Ellingsen, Joachim Schuhmacher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 14, 2019
Preclinical Efficacy of a PSMA-Targeted Thorium-227 Conjugate (PSMA-TTC), a Targeted Alpha Therapy for Prostate CancerStefanie Hammer, Urs B Hagemann, Sabine Zitzmann-Kolbe, et al.
JAMA|October 27, 2020
Association of Ticagrelor vs Clopidogrel With Net Adverse Clinical Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary InterventionSeng Chan You, Yeunsook Rho, Behnood Bikdeli, et al.
Pageof 65